Quick Answer
Celularity Inc reported Operating Income Loss of -$38.36 million for the year ending 2024.
- Celularity Inc showed an increase of +80.1% in Operating Income Loss from 2023 to 2024.
- This data is from Celularity Inc's annual report (Form 10-K), filed with the SEC on May 8, 2025.
- XBRL data for this metric is available from 2019 to 2024 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: -$545.00 | Q4 2018: -$1.1 thousand | Q1 2019: -$121.00 | Q2 2019: -$115.3 thousand | Q3 2019: -$202.0 thousand | Q1 2020: -$241.6 thousand | Q2 2020: -$208.2 thousand | Q3 2020: -$4.81 million | Q1 2021: -$44.40 million | Q2 2021: -$60.61 million | Q3 2021: $10.90 million | Q1 2022: -$41.61 million | Q2 2022: $4.18 million | Q3 2022: -$5.65 million | Q1 2023: -$63.87 million | Q2 2023: -$42.48 million | Q3 2023: -$99.26 million | Q1 2024: -$7.38 million | Q2 2024: -$10.18 million | Q3 2024: -$11.53 million | Q1 2025: -$10.49 million | Q2 2025: -$15.86 million | Q3 2025: -$12.90 million.
- Over the full 6 years of available data (2019 to 2024), Celularity Inc's Operating Income Loss has declined by 6,697.0%.
- Historical annual values: Fiscal year 2024: -$38.36 million | Fiscal year 2023: -$192.29 million | Fiscal year 2022: -$25.60 million | Fiscal year 2021: -$109.06 million | Fiscal year 2020: -$151.93 million | Fiscal year 2019: -$564.3 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: